Evidence map›Paper›PMID 21960285›Full record

ArticleDigestive diseases and sciences2012

Endoscopic management of duodenal adenomas in familial adenomatous polyposis--a single-center experience.

Sathya Jaganmohan, Patrick M Lynch, Ramu P Raju, William A Ross, Jeffrey E Lee, Gottumukkala S Raju, Manoop S Bhutani, Jason B Fleming, Jeffrey H Lee

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06435533 (Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous Polyposis), which is not on this map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06435533 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous Polyposis

TypeinterventionalSponsorUniversitätsklinikum Hamburg-EppendorfRan2023 to 2025Enrolled10ConditionsAdenomatous Polyposis Coli, Familial Adenomatous Polyposis, Duodenal AdenomaArmslow energy argonplasma coagulation
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Guideline
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Duodenal adenocarcinoma: Advances in diagnosis and surgical management.World journal of gastrointestinal surgery · 2016
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sathya JaganmohanDepartment of Gastroenterology, MD Anderson Cancer Center, Houston, TX, USA.
Patrick M Lynch
Ramu P Raju
William A Ross
Jeffrey E Lee
Gottumukkala S Raju
Manoop S Bhutani
Jason B Fleming
Jeffrey H Lee
The University of Texas MD Anderson Cancer Center · USScripps MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
6 · The paper itself

Abstract

backgroundDuodenal lesions (DLS) are common in patients with familial adenomatosis polyposis (FAP), and screening for duodenal adenocarcinoma (DA) is currently recommended. Endoscopic treatment of DLS is controversial.

aimTo report management and outcomes of endoscopic therapy for DLS in patients with FAP.

methodsThe records of patients with FAP who underwent endoscopic surveillance or therapy for DLS over a 15-year period were reviewed. Endoscopic intervention included endoscopic surveillance with biopsies, argon plasma coagulation (APC), endoscopic mucosal resection (EMR), EMR with APC, and ampullectomy. Main outcome measurements were recurrence and histology of DLS after endoscopic therapy, complications of endoscopic therapy, and need for duodenectomy.

resultsSeventy-one patients with FAP and DLS were identified from our endoscopy database as undergoing upper endoscopy for screening and/or surveillance (1995-2009). Mean follow up was 4.5 years (1-15 years). Seventy of the seventy-one (98.5%) patients had multiple flat DLS. Most of the patients were followed with yearly biopsies. APC was performed in 17 patients and EMR was performed in eight patients; in five of the eight EMR patients, APC was also performed to treat the edges of EMR site. During the follow up, 17/55 (31%) patients had histological progression (HP). HP was seen in 5/16 (31%) patients who underwent APC (one was lost to follow-up) and 12/40 (30%) patients followed with biopsies alone. Recurrence of lesions was noted in all patients. Two patients underwent duodenectomy. None of the patients developed DA during follow up.

conclusionsEndoscopic surveillance with directed endotherapy for DLS in FAP is feasible and safe when diligently performed.

Indexed as

EndoscopyAdenomatous Polyposis ColiAdolescentAdultAgedAged, 80 and overAmpulla of VaterBiopsyCohort StudiesDuodenal NeoplasmsFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm Recurrence, Local

Identifiers

PMID21960285
OpenAlexW2021804646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.